MedTrace Logo

Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants

NCT07685600 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-07-06

No results posted yet for this study

Summary

The purpose of the study is to assess the pharmacokinetics (PK) of AZD4144 when administered alone and in combination with itraconazole in healthy participants.

Conditions

  • Healthy

Interventions

DRUG

AZD4144

AZD4144 will be administered orally.

DRUG

AZD4144

AZD4144 will be administered as an IV infusion.

DRUG

Itraconazole

Itraconazole will be administered orally.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-30
Primary Completion
2026-10-28
Completion
2026-10-28

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07685600 on ClinicalTrials.gov